Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Subarachnoid Hemorrhage | 6 | 2024 | 54 | 2.640 |
Why?
|
| Vasospasm, Intracranial | 2 | 2024 | 14 | 1.690 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 213 | 1.350 |
Why?
|
| Brain Ischemia | 2 | 2022 | 82 | 1.180 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 929 | 1.100 |
Why?
|
| Neurosurgical Procedures | 6 | 2024 | 217 | 1.080 |
Why?
|
| Subarachnoid Hemorrhage, Traumatic | 1 | 2024 | 2 | 0.920 |
Why?
|
| Neurosurgeons | 2 | 2021 | 22 | 0.900 |
Why?
|
| Stroke | 3 | 2022 | 241 | 0.810 |
Why?
|
| Neurosurgery | 2 | 2021 | 75 | 0.810 |
Why?
|
| Pandemics | 2 | 2020 | 176 | 0.780 |
Why?
|
| Human Activities | 1 | 2021 | 6 | 0.770 |
Why?
|
| Time | 1 | 2021 | 16 | 0.760 |
Why?
|
| Terminology as Topic | 1 | 2021 | 52 | 0.740 |
Why?
|
| Intracranial Aneurysm | 5 | 2023 | 55 | 0.690 |
Why?
|
| Education, Medical, Continuing | 1 | 2020 | 34 | 0.680 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.670 |
Why?
|
| Embolization, Therapeutic | 4 | 2017 | 45 | 0.670 |
Why?
|
| Brain Mapping | 3 | 2017 | 199 | 0.670 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 47 | 0.650 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 51 | 0.650 |
Why?
|
| Hypertension | 1 | 2022 | 305 | 0.640 |
Why?
|
| Humans | 34 | 2024 | 27143 | 0.610 |
Why?
|
| Mechanical Thrombolysis | 1 | 2017 | 3 | 0.560 |
Why?
|
| Cerebral Hemorrhage | 1 | 2017 | 90 | 0.520 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2015 | 11 | 0.500 |
Why?
|
| Polyvinyls | 1 | 2015 | 13 | 0.490 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2015 | 16 | 0.480 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 25 | 0.480 |
Why?
|
| Evidence-Based Medicine | 1 | 2015 | 141 | 0.450 |
Why?
|
| Middle Aged | 14 | 2024 | 6907 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 811 | 0.390 |
Why?
|
| Personal Protective Equipment | 2 | 2021 | 14 | 0.370 |
Why?
|
| Archaeology | 2 | 2021 | 59 | 0.360 |
Why?
|
| Retrospective Studies | 7 | 2024 | 2465 | 0.350 |
Why?
|
| Female | 16 | 2024 | 14634 | 0.340 |
Why?
|
| Aged | 10 | 2024 | 5223 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2024 | 467 | 0.320 |
Why?
|
| Subclavian Steal Syndrome | 1 | 2008 | 3 | 0.310 |
Why?
|
| Stents | 3 | 2023 | 116 | 0.310 |
Why?
|
| Postoperative Complications | 3 | 2023 | 606 | 0.300 |
Why?
|
| Treatment Outcome | 6 | 2022 | 2286 | 0.300 |
Why?
|
| Mitral Valve | 2 | 2024 | 58 | 0.280 |
Why?
|
| Adult | 9 | 2024 | 7498 | 0.280 |
Why?
|
| Cerebrovascular Circulation | 1 | 2008 | 220 | 0.270 |
Why?
|
| Male | 15 | 2024 | 13017 | 0.270 |
Why?
|
| Obesity | 2 | 2023 | 651 | 0.270 |
Why?
|
| Cerebral Angiography | 4 | 2017 | 38 | 0.270 |
Why?
|
| Achondroplasia | 1 | 2005 | 2 | 0.260 |
Why?
|
| Arachnoid Cysts | 1 | 2005 | 4 | 0.260 |
Why?
|
| Thrombectomy | 2 | 2016 | 26 | 0.260 |
Why?
|
| Palatine Tonsil | 1 | 2005 | 10 | 0.260 |
Why?
|
| Hernia | 1 | 2005 | 9 | 0.260 |
Why?
|
| Syringomyelia | 1 | 2005 | 9 | 0.250 |
Why?
|
| Endovascular Procedures | 2 | 2023 | 61 | 0.240 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2024 | 3 | 0.240 |
Why?
|
| Ventricular Septum | 1 | 2024 | 3 | 0.230 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2024 | 12 | 0.230 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2024 | 171 | 0.230 |
Why?
|
| Multimodal Imaging | 1 | 2024 | 22 | 0.230 |
Why?
|
| Hemangioendothelioma, Epithelioid | 1 | 2024 | 5 | 0.230 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2024 | 43 | 0.230 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2022 | 36 | 0.230 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2024 | 36 | 0.220 |
Why?
|
| Robotic Surgical Procedures | 1 | 2023 | 43 | 0.200 |
Why?
|
| Incidence | 1 | 2024 | 553 | 0.200 |
Why?
|
| Postoperative Period | 1 | 2022 | 67 | 0.200 |
Why?
|
| Aortic Valve | 1 | 2022 | 90 | 0.190 |
Why?
|
| Drainage | 1 | 2022 | 42 | 0.190 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 101 | 0.190 |
Why?
|
| Angiography, Digital Subtraction | 3 | 2017 | 19 | 0.190 |
Why?
|
| Geology | 1 | 2021 | 2 | 0.190 |
Why?
|
| History, 21st Century | 1 | 2021 | 49 | 0.190 |
Why?
|
| Natural Resources | 1 | 2021 | 1 | 0.190 |
Why?
|
| Microsurgery | 3 | 2011 | 45 | 0.190 |
Why?
|
| History, 20th Century | 1 | 2021 | 83 | 0.190 |
Why?
|
| Spinal Cord | 2 | 2015 | 204 | 0.180 |
Why?
|
| Patient Selection | 2 | 2015 | 143 | 0.180 |
Why?
|
| Canada | 1 | 2020 | 59 | 0.170 |
Why?
|
| Nerve Regeneration | 1 | 2020 | 12 | 0.170 |
Why?
|
| Workload | 1 | 2020 | 38 | 0.170 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 112 | 0.170 |
Why?
|
| Health Personnel | 1 | 2020 | 91 | 0.170 |
Why?
|
| Folic Acid | 1 | 2020 | 32 | 0.170 |
Why?
|
| Prospective Studies | 3 | 2024 | 1223 | 0.170 |
Why?
|
| Neurocysticercosis | 1 | 2018 | 13 | 0.150 |
Why?
|
| Curriculum | 1 | 2020 | 271 | 0.150 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2018 | 13 | 0.150 |
Why?
|
| Neurons | 1 | 2020 | 274 | 0.150 |
Why?
|
| Hydrocephalus | 1 | 2018 | 51 | 0.140 |
Why?
|
| Aged, 80 and over | 4 | 2017 | 1939 | 0.140 |
Why?
|
| Vertebral Artery Dissection | 1 | 2017 | 4 | 0.140 |
Why?
|
| Glasgow Outcome Scale | 1 | 2017 | 3 | 0.140 |
Why?
|
| Plasminogen Activators | 1 | 2017 | 7 | 0.140 |
Why?
|
| Aneurysm, False | 1 | 2017 | 18 | 0.140 |
Why?
|
| Internship and Residency | 1 | 2020 | 228 | 0.140 |
Why?
|
| Brain | 2 | 2013 | 708 | 0.130 |
Why?
|
| Risk Factors | 1 | 2022 | 2036 | 0.130 |
Why?
|
| Mobile Health Units | 1 | 2016 | 3 | 0.130 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2016 | 16 | 0.130 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 21 | 0.130 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 24 | 0.130 |
Why?
|
| Point-of-Care Systems | 1 | 2016 | 20 | 0.130 |
Why?
|
| Thrombolytic Therapy | 1 | 2016 | 37 | 0.130 |
Why?
|
| Triage | 1 | 2016 | 32 | 0.130 |
Why?
|
| Arteriovenous Malformations | 1 | 2015 | 16 | 0.130 |
Why?
|
| Cerebral Revascularization | 1 | 2015 | 11 | 0.130 |
Why?
|
| Fluoroscopy | 1 | 2015 | 34 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 2015 | 26 | 0.120 |
Why?
|
| Middle Cerebral Artery | 2 | 2015 | 48 | 0.120 |
Why?
|
| Executive Function | 1 | 2015 | 24 | 0.120 |
Why?
|
| Disease Progression | 2 | 2015 | 458 | 0.120 |
Why?
|
| United States | 1 | 2020 | 2062 | 0.120 |
Why?
|
| Aging | 2 | 2013 | 960 | 0.120 |
Why?
|
| Chronic Disease | 1 | 2015 | 265 | 0.110 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 28 | 0.110 |
Why?
|
| Motor Activity | 2 | 2013 | 145 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2015 | 365 | 0.110 |
Why?
|
| Meningeal Neoplasms | 2 | 2011 | 73 | 0.110 |
Why?
|
| Meningioma | 2 | 2011 | 79 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2018 | 368 | 0.100 |
Why?
|
| Language | 1 | 2013 | 61 | 0.100 |
Why?
|
| Child | 2 | 2015 | 2165 | 0.100 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 21 | 0.090 |
Why?
|
| Skull Base Neoplasms | 1 | 2011 | 21 | 0.090 |
Why?
|
| Thoracic Vertebrae | 2 | 2024 | 66 | 0.090 |
Why?
|
| Aneurysm | 2 | 2009 | 25 | 0.080 |
Why?
|
| DNA Methylation | 2 | 2020 | 150 | 0.080 |
Why?
|
| Basilar Artery | 1 | 2008 | 7 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 14 | 0.080 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2008 | 128 | 0.070 |
Why?
|
| Neuronavigation | 1 | 2006 | 9 | 0.070 |
Why?
|
| Ultrasonics | 1 | 2006 | 7 | 0.070 |
Why?
|
| Monitoring, Intraoperative | 1 | 2006 | 30 | 0.060 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2006 | 33 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2006 | 54 | 0.060 |
Why?
|
| Radiography | 1 | 2005 | 201 | 0.060 |
Why?
|
| Glioma | 1 | 2006 | 118 | 0.060 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2024 | 7 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 989 | 0.060 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2024 | 35 | 0.060 |
Why?
|
| Spinal Neoplasms | 1 | 2024 | 39 | 0.060 |
Why?
|
| Absorbable Implants | 1 | 2023 | 16 | 0.060 |
Why?
|
| Decompression, Surgical | 1 | 2024 | 73 | 0.050 |
Why?
|
| Analgesics | 1 | 2023 | 35 | 0.050 |
Why?
|
| Genistein | 1 | 2002 | 9 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 298 | 0.050 |
Why?
|
| Echocardiography, Doppler | 1 | 2022 | 21 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2023 | 59 | 0.050 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2013 | 13 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2022 | 133 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 104 | 0.050 |
Why?
|
| Feasibility Studies | 1 | 2022 | 191 | 0.050 |
Why?
|
| Arabia | 1 | 2021 | 1 | 0.050 |
Why?
|
| Mesopotamia | 1 | 2021 | 1 | 0.050 |
Why?
|
| Climate | 1 | 2021 | 29 | 0.050 |
Why?
|
| History, Ancient | 1 | 2021 | 35 | 0.050 |
Why?
|
| Conservation of Natural Resources | 1 | 2021 | 26 | 0.050 |
Why?
|
| Oxygen | 2 | 2013 | 230 | 0.040 |
Why?
|
| Elective Surgical Procedures | 1 | 2021 | 70 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2016 | 404 | 0.040 |
Why?
|
| Pain | 1 | 2023 | 254 | 0.040 |
Why?
|
| Biodiversity | 1 | 2021 | 100 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2024 | 341 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 247 | 0.040 |
Why?
|
| Azacitidine | 1 | 2020 | 8 | 0.040 |
Why?
|
| Cadaver | 2 | 2011 | 57 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2020 | 34 | 0.040 |
Why?
|
| Hydroxamic Acids | 1 | 2020 | 18 | 0.040 |
Why?
|
| Axons | 1 | 2020 | 24 | 0.040 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 26 | 0.040 |
Why?
|
| Genome | 1 | 2020 | 53 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2020 | 166 | 0.040 |
Why?
|
| Ecosystem | 1 | 2021 | 206 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2020 | 538 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 399 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 666 | 0.040 |
Why?
|
| Remote Consultation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Reperfusion | 1 | 2016 | 7 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2016 | 36 | 0.030 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2016 | 28 | 0.030 |
Why?
|
| Young Adult | 2 | 2015 | 2629 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2016 | 85 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2016 | 42 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2016 | 112 | 0.030 |
Why?
|
| Semantics | 1 | 2013 | 11 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2015 | 851 | 0.030 |
Why?
|
| Infant | 1 | 2015 | 972 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2015 | 1099 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 388 | 0.020 |
Why?
|
| Sphenoid Sinus | 1 | 2011 | 5 | 0.020 |
Why?
|
| Orbit | 1 | 2011 | 8 | 0.020 |
Why?
|
| Facial Bones | 1 | 2011 | 7 | 0.020 |
Why?
|
| Bacteria, Aerobic | 1 | 2011 | 4 | 0.020 |
Why?
|
| Skull Base | 1 | 2011 | 34 | 0.020 |
Why?
|
| Aneurysm, Ruptured | 1 | 2011 | 17 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2011 | 94 | 0.020 |
Why?
|
| Reaction Time | 1 | 2011 | 94 | 0.020 |
Why?
|
| Seasons | 1 | 2011 | 83 | 0.020 |
Why?
|
| Neuroimaging | 1 | 2011 | 86 | 0.020 |
Why?
|
| Movement | 1 | 2011 | 95 | 0.020 |
Why?
|
| Electromyography | 1 | 2011 | 173 | 0.020 |
Why?
|
| Muscle Contraction | 1 | 2011 | 167 | 0.020 |
Why?
|
| Animals | 2 | 2020 | 10069 | 0.020 |
Why?
|
| Dissection | 1 | 2009 | 20 | 0.020 |
Why?
|
| Vertebral Artery | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cerebellum | 1 | 2009 | 41 | 0.020 |
Why?
|
| Consciousness Disorders | 1 | 2006 | 1 | 0.020 |
Why?
|
| Selection Bias | 1 | 2006 | 13 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2006 | 21 | 0.020 |
Why?
|
| Seizures | 1 | 2006 | 46 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2006 | 100 | 0.020 |
Why?
|
| Survival Rate | 1 | 2006 | 412 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2006 | 163 | 0.020 |
Why?
|
| Length of Stay | 1 | 2006 | 218 | 0.020 |
Why?
|
| Logistic Models | 1 | 2006 | 398 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 721 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 2991 | 0.010 |
Why?
|
| CpG Islands | 1 | 2002 | 24 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 74 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 573 | 0.010 |
Why?
|
| DNA | 1 | 2002 | 365 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 1494 | 0.010 |
Why?
|
| Mice | 1 | 2002 | 4467 | 0.010 |
Why?
|